Trial Profile
A study to investigate efficacy of lenalidomide-dexamethasone in patients with AL amyloidosis with relapsed or refractory clonal disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 02 Dec 2015 New trial record